You are currently viewing a new version of our website. To view the old version click .

From Epidemiology to Intervention: Addressing the Spread of Multidrug-Resistant Microorganisms

Special Issue Information

Dear Colleagues,

The global rise of multidrug‑resistant (MDR) microorganisms represents one of the most important challenges regarding public health. Understanding their epidemiology is essential for finding effective ways to counteract infection associated with MDR strains. MDR pathogens spread through complex networks involving hospitals, communities, animals, and the environment, driven by factors such as inappropriate antibiotic use, inadequate infection control practices, and global mobility. Epidemiological surveillance—combining molecular typing, real‑time data analysis, and risk factor assessment—enables researchers to track transmission routes and identify emerging hotspots. A new multifaceted approach from a One Health perspective is therefore necessary. Key strategies include strengthening antimicrobial stewardship programs, improving hygiene and sanitation, implementing rapid diagnostic tools, and promoting evidence‑based infection prevention measures. Bridging epidemiology and new therapeutical solutions could reduce the spread of MDR microorganisms and help to safeguard global health.

Dr. Silvia Di Lodovico
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • multidrug-resistant microorganisms
  • antimicrobial resistance
  • epidemiological surveillance
  • infection prevention and control
  • antimicrobial stewardship
  • one health
  • public health interventions

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Antibiotics - ISSN 2079-6382